[1]
A. . Agrawal, “Pharmacological Prevention of Severe Respiratory Syncytial Virus Infection in High-Risk Infants and Children: Maternal Immunization and Long-Acting Monoclonal Antibodies”, Indian J Pharm Drug Studies, vol. 4, no. 3, pp. 95–101, Sep. 2025, Accessed: Nov. 15, 2026. [Online]. Available: https://mansapublishers.com/ijpds/article/view/8496